CX Institutional

SEC CIK: 0001737089
Latest filing: Jul 1, 2026

SEC filings (opens in a new tab)

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by CX Institutional, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overview All 13F holders of LGND Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of LGND by CX Institutional, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−4,240−100.0%	Sold out	Holders
Q3 2021	4,240	$591.0K	<0.1%	+664+18.6%	Added	Holders
Q2 2021	3,576	$469.0K	<0.1%	+3,576	New	Holders